Latest News & Features
Biotechnology
The Board of Appeal of the European Patent Office has issued new communication summarising issues that will be discussed at a hearing on whether the EPO erred in its revocation of a patent owned by the Broad Institute. 4 November 2019
Big Pharma
Roche has entered into a $200 million agreement to licence Dicerna’s GalXC RNAi platform technology to develop novel therapies for the treatment of chronic hepatitis B. 31 October 2019
Big Pharma
The US Court of Appeals for the Federal Circuit has delivered a blow for Merck in a patent infringement dispute against Gilead, upholding one of its patents as invalid. 31 October 2019
Europe
Lawyers representing Italian medical devices company iVis Technologies have welcomed a decision of the European Patent Office to confirm the validity of one of the company’s patents, and are now pressing ahead with infringement claims against a German rival. 31 October 2019
Big Pharma
The Global Drug Facility, which provides tuberculosis treatments to those in need in 150 countries, has listed a new drug to its product catalogue. 31 October 2019
Americas
Allergan has reached a $750 million deal to resolve antitrust litigation brought against its subsidiary Forest Laboratories over Alzheimer’s drug Namenda. 29 October 2019
Americas
Swiss pharmaceutical company Novartis has filed a patent infringement lawsuit against three Indian rivals in a US federal court over proposed generics of its heart failure drug Entresto. 29 October 2019
Big Pharma
The National Committee on IP Rights of the Philippines prevented more than PHP455 million worth of counterfeit medicines and personal care products from reaching consumers in the first seven months of this year. 28 October 2019
Americas
AbbVie and AstraZeneca reached a settlement over patent suits involving their rival cancer drugs earlier this week, after nearly two years of litigation. 25 October 2019
Big Pharma
The Brazilian Federal Public Defender’s Office has filed a complaint against Gilead for hugely increasing the price of its hepatitis C drug since it gained patent protection. 24 October 2019